Packaging and storage
Preserve in tight,light-resistant containers.
Labeling
Where it is intended for use in preparing injectable or other sterile dosage forms,the label states that it is sterile or must be subjected to further processing during the preparation of injectable or other sterile dosage forms.
Identification
A:
It meets the requirements for neomycin under Thin-Layer Chromatographic Identification Test á201BNPñ.
B:
Dissolve about 10mg in 1mLof water,add 5mLof 15Nsulfuric acid,and heat at 100

for 100minutes.Allow to cool,add 10mLof xylene,and shake for 10minutes.Allow to separate,and decant the xylene layer.To the xylene layer add 10mLof
p-bromoaniline TS,and shake:a vivid pink-red color develops upon standing.
C:
Asolution (1in 20)responds to the tests for Sulfate á191ñ.
pHá791ñ:
between 5.0and 7.5,in a solution containing 33mg of neomycin per mL.
Loss on drying á731ñ
Dry about 100mg in vacuum at a pressure not exceeding 5mm of mercury at 60

for 3hours:it loses not more than 8.0%of its weight.
Other requirements
Where the label states that Neomycin Sulfate is sterile,it meets the requirements for
Sterilityand
Bacterial endotoxinsunder
Neomycin for Injection.Where the label states that Neomycin Sulfate must be subjected to further processing during the preparation of injectable dosage forms,it meets the requirements for
Bacterial endotoxinsunder
Neomycin for Injection.Where it is intended for use in preparing nonparenteral sterile dosage forms,it is exempt from the requirements for
Bacterial endotoxins.